Summit Trail Advisors’s Core Laboratories CLB Stock Holding History

Summit Trail Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,187	Closed	-$137K	–	142
2018 Q3	$137K	Sell	1,187 -114	-9%	-$12.9K	0.03%	227
2018 Q2	$164K	Buy	+1,301	New	+$158K	0.06%	154
2018 Q1	–	Sell	-850	Closed	-$100K	–	664
2017 Q4	$100K	Buy	+850	New	+$84.8K	0.01%	632

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Summit Trail Advisors's CLB Position: Q4 2018 in Review

Summit Trail Advisors sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 1,187 shares — an estimated $137K sold.

Summit Trail Advisors first reported a position in CLB in Q4 2017 and held it in 3 quarters. The position peaked at $164K in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Summit Trail Advisors reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Summit Trail Advisors sold 1,187 Core Laboratories shares in Q4 2018, an estimated $137K.
Summit Trail Advisors first reported a position in Core Laboratories in Q4 2017 and held it in 3 quarters.
Summit Trail Advisors's Core Laboratories position peaked at $164K in Q2 2018.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Summit Trail Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.